Xin Li, JianLi Hua et al.
evaporated and the residue was slowly neutralized with saturated
NaHCO3. Once the reaction was quenched, CH2Cl2 (150 mL) was added,
then the organic layer was separated. The aqueous solution was washed
twice with CH2Cl2 and dried with MgSO4. After removing the solvent,
the crude product was purified by recrystallization from methanol to
afford compound 6 (2.71 g, 73%). 1H NMR (400 MHz, CDCl3): d=
8.56 ppm (s, 1H).
N2 atmosphere. After the reaction was complete, CH2Cl2 (20 mL) was
added and the organic layer was removed by separation, and the aqueous
layer was washed with CH2Cl2 twice. All of the organic layer was collect-
ed. After removing the solvent, the crude product 10 was purified by
chromatography. 1H NMR (400 MHz, CDCl3): d=9.92 (s, 1H), 8.67 (s,
1H), 8.53 (s, 1H), 7.83 (s, 1H), 7.80–7.75, (m, 2H), 7.40 (d, 1H), 7.21 (q,
4H), 7.03 (d, 1H), 4.91–4.88 (m, 1H), 3.97–3.93 (m, 1H), 2.96–2.92 (m,
2H), 2.36 (s, 3H), 2.16–2.06 (m, 1H), 1.97 (d, 2H), 1.86–1.78 (m, 3H),
1.70–1.65 (m, 2H), 1.48 (m, 2H), 1.36–1.35 (m, 4H), 0.91 ppm (t, J=
6.8 Hz, 3H); HRMS: m/z: calcd for C38H37N4OS3: 661.2129; found:
661.2130 [M+H]+.
Synthesis of 7-Bromo-4-(4-hexylthiophen-2-yl)-[1,2,5]thiadiazolo
ACHTUNGTRENN[UNG 3,4-c]-
pyridine (7)
3-Hexylthiophene (0.48 mL) was dissolved in freshly distilled THF
(10 mL) and then cooled down to ꢀ788C for 10 min, then nBuLi
(1.60 mL, 4.02 mmol) was added dropwise to the mixture. After 30 min
of stirring at the same temperature, isopropyl borate (0.93 mL,
4.02 mmol) was slowly injected into the reaction solution. After stirring
for a further 2 h, the solution was warmed to room temperature and the
mixture was stirred overnight. The crude mixture was used without fur-
ther purification. The solution was mixed with compound 6 (1.00 g,
Synthesis of 2-{5-[-(3’-hexyl-5’-{4-(p-tolyl)-1,2,3,3a,4,8b-
hexahydrocyclopenta[b]indol-7-yl}-[2,2’-bithiophen]-5-yl)methylene]-4-
oxothiazolidin-2-ylidene}malononitrile (IDR-I).
Equimolar quantities of compound 4 (200 mg, 0.38 mmol) and DCRD
(62 mg, 0.38 mmol) in EtOH (20 mL) were stirred under basic conditions
(1 drop, 20% aqueous NaOH solution) and heated at reflux overnight.
After the reaction was complete, the solvent was removed and the mix-
ture was purified by chromatography to afford the desired product as
a black powder (120 mg, 47%). 1H NMR (400 MHz, CDCl3): d=8.90 (s,
1H), 7.71 (s, 1H), 7.53 (d, J=3.9 Hz, 1H), 7.46 (s, 1H), 7.31 (d, J=
8.2 Hz, 1H), 7.28–7.26 (m, 2H), 7.19 (s, 4H), 6.82 (s, 1H), 4.87 (s, 1H),
3.83 (s, 1H), 2.77 (s, 2H), 2.28 (s, 3H), 2.10–1.98 (m, 1H), 1.88–1.72 (m,
3H), 1.71–1.56 (m, 3H), 1.48–1.37 (m, 3H), 1.36-1.27 (m, 4H), 0.86 ppm
(t, J=6.8 Hz, 3H); 13C NMR ([D6]DMSO, 100 MHz): d=180.39, 178.35,
147.75, 147.72, 143.81, 142.00, 140.63, 139.88, 139.78, 133.86, 127.80,
126.70, 126.50, 125.41, 125.25, 123.67, 122.31, 121.18, 120.18, 118.36,
117.00, 68.75, 48.09, 45.95, 45.02, 35.27, 33.57, 31.14, 30.28, 29.62, 28.94,
24.46, 22.45, 20.87, 14.45, 14.32 ppm; HRMS: m/z: calcd for
C39H35N4OS3: 671.1973; found: 671.1974 [MꢀH]ꢀ.
4.02 mmol, 1.50 equiv),
a catalytic amount of [PdACHTUNTGNRUEGN(dppf)Cl2], K3PO4
(1.70 g, 3 equiv), H2O (2 mL), and then heated at reflux overnight under
an N2 atmosphere. After the reaction was complete, CH2Cl2 (20 mL) was
added. The organic layer was separated and the aqueous solution was
washed with CH2Cl2 twice. All of the organic solution was collected and
dried with Na2SO4. After removal of the solvent solvent by evaporation,
the crude product was purified by chromatography to afford the desired
product 7 (760 mg, 75.2%). 1H NMR (400 MHz, CDCl3): d=8.66 (s,
1H), 8.52 (s, 1H), 7.24 (s, 1H), 2.73–2.69 (m, 2H), 1.73–1.67 (m, 2H),
1.38–1.30 (m, 6H), 0.90 ppm (t, J=7.0 Hz, 3H).
Synthesis of 7-Bromo-4-(5-bromo-4-hexylthiophen-2-yl)-
[1,2,5]thiadiazoloACHTUNGTRENNUNG[3,4-c]pyridine (8)
Compound 7 (484 mg, 1.27 mmol) was dissolved in CH2Cl2 and cooled to
08C, then NBS (248 mg, 1.39 mmol) was added into the solution and the
mixture was stirred for 6 h. After the reaction was complete, CH2Cl2
(20 mL) was added and the organic layer was removed by separation.
Then the aqueous solution was washed with CH2Cl2 twice. Removal of
the solvent afforded product 8, which was used for the next step without
further purification.
Synthesis of 2-[5-({3’-hexyl-5’-(7-{4-(p-tolyl)-1,2,3,3a,4,8b-
hexahydrocyclopenta[b]indol-7-yl}benzo[c]ACTHUNTGRENNG[U 1,2,5]thiadiazol-4-yl)-[2,2’-
bithiophen]-5-yl}methylene)-4-oxothiazolidin-2-ylidene]malononitrile
(IDR-II).
Equimolar quantities of compound 5 and DCRD in EtOH (20 mL) were
stirred under basic conditions (1 drop, 20% aqueous NaOH solution)
and heated at reflux overnight. After the reaction was complete, the sol-
vent was removed and the mixture was purified by chromatography to
afford the desired product as a black powder. 1H NMR (400 MHz,
[D6]DMSO): d=8.01 (d, J=7.6 Hz, 1H), 7.96 (s, 1H), 7.81 (s, 1H), 7.72–
7.70 (m, 3H), 7.53 (d, J=4.0 Hz, 1H), 7.32 (d, J=3.9 Hz, 1H), 7.20 (q,
J=8.5 Hz, 1H), 6.91 (d, J=8.4 Hz, 1H), 4.86 (s, 1H), 3.84 (s, 1H), 2.81
(s, 2H), 2.29 (s, 3H), 2.13–1.98 (m, 1H), 1.90–1.72 (m, 3H), 1.72–1.56 (m,
3H), 1.50–1.36 (m, 3H), 1.36–1.27 (m, 4H), 0.86 ppm (t, 3H); 13C NMR
(100 MHz,[D6]DMSO): d=180.12, 178.20, 152.97, 151.86, 147.50, 140.71,
139.50, 139.43, 134.96, 130.79, 129.73, 128.71, 127.91, 126.42, 125.85,
125.20, 122.70, 119.48, 106.73, 68.28, 47.72, 44.55, 33.08, 31.00, 30.94,
29.84, 28.72, 23.96, 22.06, 20.37, 13.94 ppm; HRMS: m/z calcd for
C45H39N6OS4: 807.2068; found: 807.2068 [M+H]+.
Synthesis of 4-(5-Bromo-4-hexylthiophen-2-yl)-7-{4-(p-tolyl)-1,2,3,3a,4,8b-
hexahydrocyclopenta[b]indol-7-yl}-[1,2,5]thiadiazolo
ACHTUNGTREN[NUNG 3,4-c]pyridine (9)
Compound 8 (490 mg, 1.07 mmol), compound 5 (an excess amount), a cat-
alytic amount of [Pd(dppf)Cl2], K2CO3 (1.38 g, 10 mmol), and solution of
ACHTUNGTRENNUNG
THF (25 mL) and H2O (5 mL) were added to a 50 mL round-bottomed
flask. Then the mixture was heated at reflux overnight under an N2 at-
mosphere. After the reaction was complete, CH2Cl2 (20 mL) was added
and the organic layer was removed by separation, and then the aqueous
solution was washed with CH2Cl2 twice. All of the organic solution was
collected. After removing the solvent, the residue was purified by chro-
matography to afford desired compound 9 (420 mg, 62.6%). 1H NMR
(400 MHz, CDCl3): d=8.61 (s, 1H), 8.34 (s, 1H), 7.80 (s, 1H), 7.74 (d,
J=8.3 Hz, 1H), 7.25–7.17 (m, 4H), 7.02 (d, J=8.4 Hz, 1H), 6.82 (d, J=
8.4 Hz, 1H), 4.90–4.87 (m, 1H), 3.94 (t, J=8.3 Hz, 1H), 2.66 (t, J=
7.7 Hz, 2H), 2.36 (s, 3H), 2.10–2.06 (m, 2H), 1.94 (s, 2H), 1.84–1.76 (m,
1H), 1.72–1.66 (m, 3H), 1.37 (m, 6H), 0.91 ppm (t, J=6.9 Hz, 3H); 13C
NMR (CDCl3, 100 MHz): d=155.32, 147.88, 147.07, 143.41, 142.97,
140.35, 140.35, 138.83, 134.67, 130.97, 130.70, 128.82, 127.74, 126.02,
124.26, 123.14, 119.50, 114.15, 106.53, 68.29, 44.34, 34.22, 32.62, 30.62,
28.82, 28.68, 27.93, 23.40, 21.60, 19.82, 13.10 ppm; HRMS: m/z: calcd for
C33H34BrN4S2: 629.1408; found: 629.1403 [M+H]+.
Synthesis of 2-[5-({3’-Hexyl-5’-(7-{4-(p-tolyl)-1,2,3,3a,4,8b-
hexahydrocyclopenta[b]indol-7-yl}-[1,2,5]thiadiazoloACHTNUTRGNEUNG[3,4-c]pyridin-4-yl)-
[2,2’-bithiophen]-5-yl}methylene)-4-oxothiazolidin-2-
ylidene]malononitrile (IDR-III).
Equimolar quantities of compound 10 (196 mg, 0.297 mmol) and DCRD
(48.7 mg, 0.297 mmol) in EtOH (20 mL) were stirred under basic condi-
tions (1 drop, 20% aqueous NaOH solution) and heated at reflux over-
night. After the reaction was complete, the solvent was removed and the
mixture was purified by chromatography to afford the desired product as
a black powder. 1H NMR (400 MHz, CDCl3): d=8.64 (s, 1H), 8.49 (s,
1H), 7.81 (s, 1H), 7.74 (d, J=8.2 Hz, 1H), 7.71 (s, 1H), 7.32 (s, 2H),
7.23–7.17 (m, 4H), 7.03 (d, J=8.6 Hz, 1H), 4.89 (s, 1H), 3.95 (s, 1H),
2.93 (s, 2H), 2.35 (s, 3H), 2.16–2.04 (m, 1H), 2.02–1.90 (m, 3H), 1.83–
1.77 (m, 6H), 1.55–1.45 (m, 4H), 0.89 ppm (t, J=6.8 Hz, 3H); 13C NMR
(100 MHz, [D8]THF): d=179.08, 176.53, 154.16, 146.7, 146.20, 142.17,
139.92, 139.01, 138.87, 138.20, 137.83, 133.55, 132.50, 131.95, 130.18,
Synthesis of 3’-Hexyl-5’-(7-{4-(p-tolyl)-1,2,3,3a,4,8b-
hexahydrocyclopenta[b]-indol-7-yl}-[1,2,5]thiadiazolo
[2,2’-bithiophene]-5-carbaldehyde (10)
ACHTUNGERTN[NUNG 3,4-c]pyridin-4-yl)-
Compound 9 (380 mg, 0.605 mmol), 5-formyl-2-thiopheneboronic acid
(122.7 mg, 0.786 mmol, 1.3 equiv), a catalytic amount of [Pd(PPh3)4], and
AHCTUNGTRENNUNG
K2CO3 (1.38 g) were dissolved in a mixed solvent of THF (20 mL) and
H2O (5 mL). Then the mixture was heated at reflux overnight under an
&
&
8
Chem. Asian J. 2014, 00, 0 – 0
ꢂ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!